Swissmedic closely monitoring international developments around the drug Tavneos.
Swissmedic is monitoring the Tavmeos drug situation
Keystone
Switzerland’s drugs regulator Swissmedic is closely monitoring international developments around the drug Tavneos following warnings from Japan about several deaths.
Generated with artificial intelligence.
This content was published on
Amgen stands by Tavneos, despite reports of 20 deaths in Japan
FDA seeks to withdraw avacopan approval over alleged data manipulation, false statements
Merck, Kelun score with sac-TMT in endometrial cancer trial
Novartis terminates plant contract with Chinese CDMO Porton, threatens $64M in legal claims
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug
Pharmas & Medtech - Le Temps
Latte per neonati contaminato e i ritiri silenziosi in Europa - RSI
